Compliance dose indicator
Latest SmithKline Beecham Corporation Patents:
- Apparatus for producing a pharmaceutical product
- Apparatus and method for producing a pharmaceutical product
- Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
- Apparatus and method for producing or processing a product or sample
- Method for customized dispensing of variable dose drug combination products for individualizing of therapies
Description
The broken lines depict environmental subject matter only and form no part of the claimed design.
Claims
The ornamental design for a compliance dose indicator, as shown and described.
Referenced Cited
U.S. Patent Documents
1477123 | December 1923 | Hopkins |
1659325 | February 1928 | Merrell |
D92405 | June 1934 | Klebanow |
1971528 | August 1934 | Klebanow |
2340719 | February 1944 | Walter |
D359989 | July 4, 1995 | Sukovich |
D370386 | June 4, 1996 | Pallesen |
D412938 | August 17, 1999 | Kesselring et al. |
D535194 | January 16, 2007 | Spencer et al. |
D556602 | December 4, 2007 | Clements et al. |
D585944 | February 3, 2009 | Lee |
Patent History
Patent number: D606861
Type: Grant
Filed: Jun 4, 2008
Date of Patent: Dec 29, 2009
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Inventor: Larry D. Pavlinac (Durham, NC)
Primary Examiner: Susan Bennett Hattan
Attorney: Robert J. Smith
Application Number: 29/319,122
Type: Grant
Filed: Jun 4, 2008
Date of Patent: Dec 29, 2009
Assignee: SmithKline Beecham Corporation (Philadelphia, PA)
Inventor: Larry D. Pavlinac (Durham, NC)
Primary Examiner: Susan Bennett Hattan
Attorney: Robert J. Smith
Application Number: 29/319,122
Classifications
Current U.S. Class:
D9/434